![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
The relationship expands Reakiro’s product portfolio from CBD food supplements and cosmetics to include medicinal cannabis products that can be supplied on a prescription basis by pharmacies, clinics, and hospitals globally.
Lead Product(s): Cannabidiol,Tetrahydrocannabinol
Therapeutic Area: Neurology Product Name: Estratt
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: A2W Pharma
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership November 21, 2022